PCR For Respiratory Infection Diagnostic Market is expected to reach US$ 8279.32 Mn With CAGR of 10.4% from 2021 to 2028 | Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc.; Seegene Inc.; AusDiagnost

According to our new research study on “PCR for respiratory infection diagnostics market” Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Product Type, Infection Type, End User,” the market is expected to reach US$ 8279.32 million by 2028 from US$ 4,146.02 million in 2021; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.

Request for sample PDF Copy https://www.theinsightpartners.com/sample/TIPRE00023326/?openpr-10225

The PCR for respiratory infection diagnostics market is segmented real time PCR (qPCR), multiplex PCR, traditional PCR, digital PCR, reverse transcriptase PCR (RT-PCR) and others. The real time PCR held the largest share in 2021, also the same segment is anticipated to register the highest CAGR in the market during the coming years. Real Time PCR Real-time reverse transcription polymerase chain reaction (RT–PCR) is a nuclear-based approach for identifying the presence of specific genetic material in any disease, including viruses. Originally, radioactive isotope markers are used to detect specific genetic elements, but later improvement has resulted in the application of specialized markers, most often fluorescent dyes, to replace isotopic labelling.

Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc.; Seegene Inc.; AusDiagnostics; BD; bioMérieux SA; and Qiagen are among the leading companies operating in the PCR for respiratory infection diagnostics market.

Market Insights

Market Consolidations Strategies Adopted by Use of PCR Testing for Various Respiratory Infection Diagnostics

PCR testing is the gold standard for detecting respiratory infectious diseases, including SARS-CoV-2. Also, the growing developments in PCR are not limited to the COVID-19 testing. The continuous technological developments have allowed researchers to develop advanced PCR techniques at a reduced cost and limit their complexities. It is expected that PCR testing will enhance its capabilities for molecular diagnostics and strengthen its role in the future with the ongoing developments of technologies such as microfluidics and next-generation sequencing. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals, for identifying influenza virus infection that causes respiratory outbreaks.

Moreover, acute and chronic respiratory infections are among the leading causes of morbidities in the developed and developing countries globally. It is estimated that acute respiratory diseases account for nearly 75% of the total acute morbidities globally. Therefore, various companies are offering various PCR kits that can detect the presence of pathogens that cause respiratory diseases. For instance, companies such as bioMérieux SA and altona Diagnostics GmbH provide a wide range of PCR kits that can detect acute respiratory infection in the upper or lower respiratory tract. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the coming future.

The report segments the pcr for respiratory infection diagnostics market as follows:

By Type

Real-Time PCR (qPCR)
Multiplex PCR
Traditional PCR
Digital PCR
Reverse-Transcriptase (RT-PCR)
Others

By Product Type

Reagents and Kits
Instruments
Others

By Infection Type

Bacterial Infections
Bordetella
Streptococcus Pneumoniae
Staphylococcus Aureus
Haemophilus Influenzae
Moraxella Catarrhalis
Mycoplasma Pneumoniae
Chlamydophila Pneumoniae
Legionella
Others
Viral Infections
Rhinoviruses
Influenza Virus
Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
Respiratory Syncytial Virus (RSV)
Adenovirus
Enterovirus
Parainfluenza
Human Metapneumovirus (hMPV)
Others
Fungal and Other Pathogens

By End User

Hospitals
Physician Clinics
Clinical Laboratories
Academic and Research Institutions
Biotech and Pharma Companies
Others

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Netherlands
Norway
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of Middle East and Africa
South and Central America (SCAM)
Brazil
Argentina
Rest of South and Central America

Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPRE00023326/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

ABOUT US:
The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.